MedTrace Logo

Testosterone Undecanoate and Quality of Life of Men and Spouses

NCT01758029 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2012-12-31

No results posted yet for this study

Summary

This study will be conducted as a prospective, single-center (multiple clinics), single-arm open phase IV study.

the study will follow hypogonadal patients, and aimed to confirm the hypothesis that testosterone undecanoate improves the patient satisfaction and quality of life, with parallel improvement in their spouses's quality of life and satisfaction. Each patient/spouse will serve as his own control.

Conditions

  • Hypogonadism

Interventions

DRUG

testosterone undecanoate

treatment with testosterone undecanoate 1000mg intramuscular, at week 0, week 6, week 18.

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • uri gur, MD · Israel: Clalit Health Services

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-07-31
Completion
2014-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758029 on ClinicalTrials.gov